MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $69,000 | +11.3% | 10,818 | -5.6% | 0.00% | – |
Q2 2016 | $62,000 | -31.1% | 11,458 | +5.8% | 0.00% | – |
Q1 2016 | $90,000 | -96.1% | 10,833 | -96.0% | 0.00% | -100.0% |
Q3 2015 | $2,309,000 | -47.5% | 271,409 | -23.6% | 0.00% | -66.7% |
Q2 2015 | $4,395,000 | +289.6% | 355,425 | +274.6% | 0.00% | +200.0% |
Q1 2015 | $1,128,000 | -24.1% | 94,880 | -27.9% | 0.00% | 0.0% |
Q4 2014 | $1,487,000 | +36.8% | 131,569 | +6.3% | 0.00% | 0.0% |
Q3 2014 | $1,087,000 | – | 123,811 | +412603.3% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 30 | -99.5% | 0.00% | – |
Q3 2013 | $23,000 | -41.0% | 6,143 | +6.0% | 0.00% | – |
Q2 2013 | $39,000 | – | 5,794 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |